Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

Cancer

Volumn 120, Issue 18, 2014, Pages 2847-2854

  De Glas, Nienke A ^a   Fontein, Duveken B Y ^a   Bastiaannet, Esther ^a   Pijpe, Anouk ^b   De Craen, Anton J M ^a   Liefers, Gerrit Jan ^a   Nortier, Hans J R ^a   De Haes, Hanneke J C J M ^c   Van De Velde, Cornelis J H ^a   Van Leeuwen, Flora E ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Breast cancer; Endocrine therapy; Older patients; Physical activity; Postmenopausal patients

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; EXEMESTANE; TAMOXIFEN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; DISEASE ASSOCIATION; FEMALE; HABIT; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PHYSICAL ACTIVITY; POSTMENOPAUSE; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; SURVIVAL RATE; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FOLLOW UP; HORMONAL THERAPY; METABOLISM; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OLDER PATIENTS; PATHOLOGY; PHYSIOLOGY; POSTMENOPAUSAL PATIENTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TUMOR RECURRENCE; VERY ELDERLY;

BREAST CANCER; ENDOCRINE THERAPY; OLDER PATIENTS; PHYSICAL ACTIVITY; POSTMENOPAUSAL PATIENTS;

ADULT; AGED; AGED, 80 AND OVER; ANDROSTADIENES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTMENOPAUSE; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84908025484     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28783     Document Type: Article

References (35)

1. Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;344: e70.
2. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175:34-41.
3. Monninkhof EM, Elias SG, Vlems FA, et al. Physical activity and breast cancer-a systematic review. Epidemiology. 2007;18:137-157.
4. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293:2479-2486.
5. Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol. 2007;25:2345-2351.
6. Fontein DB, de Glas NA, Duijm M, et al. Age and the effect of physical activity on breast cancer survival: a systematic review. Cancer Treat Rev. 2013;39:958-965.
7. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001;285:885-892.
8. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37-43.
9. Bastiaannet E, Liefers GJ, de Craen AJ, et al. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127, 805 unselected patients. Breast Cancer Res Treat. 2010;124:801-807.
10. Avis NE, Deimling GT. Cancer survivorship and aging. Cancer. 2008;113(suppl):3519-3529.
11. van de Velde CJ, Rea D, Seynaeve C, et al. Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet. 2011;377:321-331.
12. Voskuil DW, van Nes JG, Junggeburt JM, van de Velde CJ, van Leeuwen FE, de Haes JC. Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol. 2010;21:2094-2101.
13. Cust AE, Smith BJ, Chau J, et al. Validity and repeatability of the EPIC physical activity questionnaire: a validation study using acceler-ometers as an objective measure. Int J Behav Nutr Phys Act. 2008;5:33.
14. Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71-80.
15. Irwin ML, Smith AW, McTiernan A, et al. Influence of pre-and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol. 2008; 26:3958-3964.
16. Gast GC, Frenken FJ, van Leest LA, Wendel-Vos GC, Bemelmans WJ. Intra-national variation in trends in overweight and leisure time physical activities in the Netherlands since 1980: stratification according to sex, age and urbanisation degree. Int J Obes (Lond). 2007;31:515-520.
17. van de Water W, Kiderlen M, Bastiaannet E, et al. External validity of a trial comprising elderly patients with hormone-receptor positive breast cancer. J Natl Cancer Inst. 2014;106:dju051.
18. van de Water W, Markopoulos C, van de Velde CJ, et al. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer. JAMA. 2012;307:590-597.
19. Seguin R, Buchner DM, Liu J, et al. Sedentary behavior and mortality in older women: the Women's Health Initiative. Am J Prev Med. 2014;46:122-135.
20. Mulligan AM, O'Malley FP, Ennis M, Fantus IG, Goodwin PJ. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res Treat. 2007;106:39-47.
21. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627-635.
22. Boyle P, Boniol M, Koechlin A, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107:1608-1617.
23. Hardefeldt PJ, Edirimanne S, Eslick GD. Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer. 2012;19:793-803.
24. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer. 2008;8:205-211.
25. Reeves KW, Faulkner K, Modugno F, et al. Body mass index and mortality among older breast cancer survivors in the study of osteo-porotic fractures. Cancer Epidemiol Biomarkers Prev. 2007;16:1468-1473.
26. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol. 1996;6:376-380.
27. Braithwaite D, Satariano WA, Sternfeld B, et al. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010;102:1468-1477.
28. Cancer Research UK. Breast cancer incidence statistics. Available at: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/incidence/uk-breast-cancer-incidence-statistics. Accessed March 13, 2013.
29. Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26:783-790.
30. van de Water W, Bastiaannet E, Dekkers OM, et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg. 2012;99:813-820.
31. Gaillard S, Stearns V. Aromatase inhibitor-associated bone and mus-culoskeletal effects: new evidence defining etiology and strategies for management. Breast Cancer Res. 2011;13:205.
32. Diab SG, Elledge RM, Clark GM. RESPONSE: re: tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2001;93:65-66.
33. van de Water W, Bastiaannet E, Hille ET, et al. Age-specific non-persistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis. Oncologist. 2012;17:55-63.
34. Friedenreich CM, Gregory J, Kopciuk KA, Mackey JR, Courneya KS. Prospective cohort study of lifetime physical activity and breast cancer survival. Int J Cancer. 2009;124:1954-1962.
35. Statistics Netherlands. Gezondheidskenmerken, leefstijl, zorggebruik t/m 2009. Accessed April 12, 2013. http://statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=03799&D1=0-50, 54-57, 59, 78-90, 202-298&D2=0-17&D3=0&D4=a&VW=T.